Sanofi, Axa, Aviva, Pro BTP and CNP Assurances were among the backers of the vehicle, which will focus on biotech investments.

The diabetes management system developer, a spinoff of Sarnoff Corporation, has filed to raise up to $75m in a Nasdaq offering.

Great Hill Partners supplied the series F funding for the McKesson Ventures-backed infusion network operator.

The mobile health app developer's series C round was led by Susquehanna International Group and also featured Horizon Healthcare Services.

UChicago spinout NowPow has been acquired by Unite Us for an undisclosed amount.

Oracle has committed $205m to an initial public offering for the DNA sequencing technology developer with a $410m target for its close.

Illumina has anchored the second fund to be closed by the venture firm it sponsors, with Ireland Strategic Investment Fund among the limited partners.

The cancer treatment developer is set to go public in an offering which would represent exits for Pfizer Ventures, Leaps by Bayer and Ipsen.

Arctos Medical, which is developing gene therapies to treat sight loss, had raised $8.1m from investors including Novartis two years ago.

University of Bern spinout Arctos Medical has been acquired by existing shareholder Novartis.